Buspirone transdermal patch data

SANO announced results of a Phase II trial conducted by partner Bristol-Myers Squibb (Princeton, N.J.) using BMS's

Read the full 173 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE